Results 11 to 20 of about 137,395 (319)

Post-Acute Withdrawal Syndrome: The Major Cause of Relapse among Psychoactive Substances Addicted Users [PDF]

Archives Of Pharmacy Practice, 2021
Mona Yaser Alsheikh
openalex   +2 more sources

Overview of withdrawal syndrome mechanisms in different substance abuse addictions: Neuronal circuits and transmitters [PDF]

Journal of Addiction Medicine and Therapeutic Science, 2020
Substance abuse is one of the major concerns of human societies. Many problems exist for controlling drug abuse that profoundly influences treatment. One of the most important and prevalent problems is Withdrawal Syndrome (WS).
Famitafreshi Hamidreza, Karimian Morteza
openalex   +4 more sources

Is Clonidine Useful for the Management of Tramadol-induced Withdrawal Syndrome? [PDF]

Asia Pacific Journal of Medical Toxicology, 2022
Dear Editor-in-chiefTramadol is a synthetic opioid with non-opioid effects. It has a low affinity to opioid receptors and inhibits re-uptake of norepinephrine and serotonin in synapses [1- 5].
Mohammad Majidi, Solmaz Nekoueifard, Bita Dadpour   +2 more
doaj   +1 more source

The therapeutic use and efficacy of ketamine in alcohol use disorder and alcohol withdrawal syndrome: a scoping review

Frontiers in Psychiatry, 2023
Introduction Alcohol use disorder (AUD) is the most prevalent substance use disorder (SUD) globally. In 2019, AUD affected 14.5 million Americans and contributed to 95,000 deaths, with an annual cost exceeding 250 billion dollars.
C. Goldfine, J. J. Tom, D. Im, Benjamin L. Yudkoff, A. Anand, Joseph J. Taylor, P. Chai, J. Suzuki   +7 more
semanticscholar   +1 more source

A Retrospective Review Following the Addition of Clonidine to a Neonatal Abstinence Syndrome Treatment Algorithm

Frontiers in Pediatrics, 2021
Objective: To investigate the outcomes associated with the implementation of a neonatal abstinence syndrome (NAS) treatment algorithm utilizing dual therapy with morphine sulfate and clonidine in a level four neonatal intensive care unit (NICU).Study ...
Mohammad Y. Bader, Mohammad Y. Bader, Nahla Zaghloul, Nahla Zaghloul, Ashley Repholz, Nadia Nagy, Nadia Nagy, Mohamed N. Ahmed, Mohamed N. Ahmed, Leslie Thompson, Ranjit I. Kylat, Ranjit I. Kylat   +11 more
doaj   +1 more source

Efficacy of Lofexidine in the Outpatient Management of Tramadol Withdrawal Syndrome

International Journal of Medical Toxicology and Forensic Medicine, 2020
Tramadol is recognized as an opioid with non-opiate properties. It has a low affinity for opioid receptors and prevents reabsorption of norepinephrine and serotonin at synapses. It also increases the level of Gamma Aminobutyric Acid (GABA) in the central
Mohammad Majidi , Solmaz Nekoueifard
doaj   +1 more source

Using Named Entity Recognition to Identify Substances Used in the Self-medication of Opioid Withdrawal: Natural Language Processing Study of Reddit Data

JMIR Formative Research, 2022
BackgroundThe cessation of opioid use can cause withdrawal symptoms. People often continue opioid misuse to avoid these symptoms. Many people who use opioids self-treat withdrawal symptoms with a range of substances.
Alexander Preiss, Peter Baumgartner, Mark J Edlund, Georgiy V Bobashev   +3 more
doaj   +1 more source

Cognitive and Mental Health Predictors of Withdrawal Severity During an Active Attempt to Cut Down Cannabis Use

Frontiers in Psychiatry, 2018
A milestone in cannabis research is the establishment of a clinically relevant cannabis withdrawal syndrome, yet little is known about the underlying mechanisms.
Janna Cousijn, A. C. K. van Duijvenvoorde, A. C. K. van Duijvenvoorde   +2 more
doaj   +1 more source

The relationship between addiction and hikikomori tendencies: a case-control study

Frontiers in Psychiatry, 2023
AimThe present study examined the relationship between addiction and hikikomori (extreme social withdrawal) symptoms.MethodA group of clinically referred addiction patients (n = 31) and a group of age- and gender-matched non-clinical controls (n = 34 ...
Peter Muris, Veerle van de Pasch, Veerle van de Pasch, Janno van Kessel, Josine Peet   +4 more
doaj   +1 more source

DSM-5 criteria for substance use disorders: recommendations and rationale. [PDF]

, 2013
Since DSM-IV was published in 1994, its approach to substance use disorders has come under scrutiny. Strengths were identified (notably, reliability and validity of dependence), but concerns have also arisen.
Auriacombe, Marc, Borges, Guilherme, Bucholz, Kathleen, Budney, Alan, Compton, Wilson M, Crowley, Thomas, Grant, Bridget F, Hasin, Deborah S, Ling, Walter, O'Brien, Charles P, Petry, Nancy M, Schuckit, Marc   +11 more
core   +1 more source